Helmy M. Siragy, MD, FACP, FAHA is the Harrison Distinguished Chair of Excellence in Medical Education and a Professor of Medicine and Endocrinology at the University of Virginia in Charlottesville, Virginia, USA.  He is a fellow of the American College of Physicians and the American Heart Association and is a member of numerous national and international endocrine and hypertension societies. He is a member of multiple national and international committees including the American Heart Association and the United States National Institutes of Health. He is a member of the editorial boards of several hypertension, endocrine, vascular biology and kidney journals and is currently a member of the Nature Research Group Editorial Board and Guest Editor of the Nature publication Scientific Reports “Cardio-Renal Axis” and the International Journal of Medical Sciences Special Issue “Angiotensin in Human Health and Diseases”. Dr. Siragy was the first to discover and publish on the fact that stimulation of the angiotensin AT2 receptor leads to the generation of nitric oxide.  Dr. Siragy has authored more than 250 medical journal articles and twenty-five medical textbook chapters, Dr. Siragy's primary research interests are in the areas of the renin-angiotensin system, hypertension, cardiac ischemia, hepato-adrenal syndrome, and diabetic kidney disease.